News

Whale Investors Make Bold Moves with Target Stock TGT Trading

Whale Investors Make Bold Moves with Target Stock TGT Trading

Whale activity around Target (TGT)

Large, active traders have been leaning into Target’s options recently. In reviewing the options tape for Target (TGT), we flagged 11 notable trades from bigger participants—moves that help show where confident capital is positioning and how risk is being managed.

How investors are positioning

Across those trades, sentiment wasn’t one-sided: 36% of the activity looked bullish and 36% skewed bearish, with the rest not clearly directional. Of the 11 trades, 4 were puts totaling about $168,767, while 7 were calls with a combined value of $235,142. That mix suggests interest in upside exposure, but also an active use of downside protection.

Price levels drawing the most focus

Pairing trading volumes with open interest points to a price zone that keeps coming up: $120.00 to $180.00. That band appears to be where larger players have concentrated their activity in recent months, reflecting both expectations for where shares could trade and the range many are hedging around.

Volume and open interest, in plain terms

Volume shows how many contracts changed hands today. Open interest shows how many are still open. Together, they’re a quick read on liquidity and where attention sits at specific strikes. For Target, the notable trades over the last month clustered in the $120.00 to $180.00 strike range for both calls and puts—an area with enough depth for bigger orders to get done without moving markets too much.

Target’s call and put activity: recent snapshot

In the recent batch of significant prints, calls outnumbered puts 7 to 4 and carried a larger combined notional value ($235,142 in calls versus $168,767 in puts). Even so, the distribution across both sides signals positioning that’s opportunistic, not all-in.

Highlights from the largest observed options trades

The heftiest trades were concentrated within that $120.00–$180.00 window. Some sought leveraged upside via calls, others leaned on puts for protection or directional bets. Read together, the tape implies traders are bracing for movement while respecting that range.

Target’s market presence

Target is the seventh-largest retailer in the nation, known for pairing a smooth in-store experience with a broad mix of on-trend apparel, home goods, and everyday essentials at competitive prices. Since the 1990s, it has cultivated a stylish, slightly upscale brand identity—an approach that’s supported steady revenue growth and helped it secure a durable place among leading U.S. retailers.

Current status of Target (TGT)

  • Shares recently traded with volume of 700,517 and were down -0.67%, at $149.58.
  • RSI readings suggest the stock may be nearing overbought territory.
  • The next earnings release is expected in 64 days, a timing milestone many option strategies are built around.

Analysts weigh in on Target

Over the past month, five analysts updated their views, with an average price target of $165.2:

  • Roth MKM: Neutral rating, $157 target.
  • Oppenheimer: Outperform rating, $180 target.
  • TD Cowen: Hold rating, $180 target.
  • Stifel: Hold rating, $147 target.
  • Truist Securities: Hold rating, $162 target.

Options can magnify both gains and losses. Seasoned traders try to keep risk in check by sizing positions carefully, adjusting as conditions change, and staying close to the data—volume, open interest, and the calendar.

Frequently Asked Questions

What stood out in the recent TGT options activity?

We tracked 11 notable trades from larger players. Sentiment split evenly—36% bullish and 36% bearish—signaling active positioning on both sides rather than a one-way bet.

Which price range are traders circling for TGT?

The options tape and open interest point to a $120.00–$180.00 focus. That’s the range where bigger orders have gathered in recent months.

How do calls and puts compare in the latest data?

Calls outnumbered puts 7 to 4 and carried higher combined value ($235,142 in calls versus $168,767 in puts), indicating interest in upside while still respecting downside risk.

Where is the stock trading right now?

Target (TGT) recently traded at $149.58, down -0.67% on volume of 700,517. RSI signals suggest it may be nearing overbought territory.

What’s the current analyst view on TGT?

Five analysts weighed in over the last month with an average target of $165.2. Ratings range from Hold to Outperform, with price targets spanning $147 to $180.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Astemo Flexes Aftermarket Muscles at 2026 AAPEX & SEMA

Updated Category News Views 90

Ah, nothing gets car enthusiasts more revved up than a good old-fashioned auto show unveiling. Astemo Americas is strutting its stuff at the 2026 AAPEX and SEMA shows, and they're not just shooting the breeze—this company has got some serious aftermarket muscle to flex. Pumping Up the Aftermarket Game Astemo's not sitting on its hands when it comes to expanding its...

Continue Reading
Ping An Shows Resilient Growth Amid Economic Pressure

Updated Category News Views 18

Unpacking Ping An's Steady Climb Amid Tumult A few eyebrows might have raised when Ping An Insurance unveiled its nine-month report for 2026. Despite economic turbulence in China—courtesy of a gnarly global scene—the numbers were anything but rattled. Operating profit rose 8.3% year over year to a beefy RMB125,905 million. The equity pool swelled by 4.4% as of...

Continue Reading
Beacon AI's Murdock Flies into the Future for USAF

Updated Category News Views 69

Advancing AI in the Skies Nothing quite shakes up the aviation scene like a debut flight of a new AI system aboard real-deal military planes. Beacon AI is throwing down its AI pilot assistant system, Murdock, on the table—its pride and joy just completed five flights on KC-46A Pegasus craft, sanctioned by no less than the U.S. Air Force itself. Grit and Innovation: The...

Continue Reading
Lynk Pharmaceuticals' Zemprocitinib Shines in Phase III RA Trial

Updated Category News Views 86

A Deep Dive into Lynk Pharmaceuticals' Latest Revelation Lynk Pharmaceuticals just dropped a bombshell with their latest Phase III trial results for zemprocitinib. This selective JAK1 inhibitor seems to be bringing some serious game in the fight against moderate-to-severe rheumatoid arthritis (RA), especially for folks who haven't had much luck with biologics. The drug...

Continue Reading
Baystate Health's Pilot Eases Access to Medical Services

Updated Category News Views 98

Rethinking Healthcare Access with Baystate Health Now here's a bit of news that doesn't make you wanna choke on your coffee: Baystate Health's Clear Path Pilot Program is shaking things up in the healthcare game, and it's about time. The initiative, rolling out with Health New England, is like waving a magic wand over the usual bureaucratic mess of prior authorizations....

Continue Reading
Astellas and Audax Forge $1.34B Immuno-Oncology Deal

Updated Category News Views 100

Big Moves in Immuno-Oncology: Astellas' Latest Bet You hear 'immuno-oncology,' you think breakthrough, right? Well, friends, that's what Astellas and Audax Biosciences are shooting for with their fresh handshake over DAX-044. On October 27, 2026, in Tokyo and Melbourne, the two outfits announced they're joining forces to bring this novel immunotherapy to the table. It's...

Continue Reading
Singapore's New Leap in Healthcare Innovation with IMDA-NUH Partnership

Updated Category News Views 0

A Groundbreaking Partnership in Singapore's Healthcare Sector Every so often, something big comes along that makes you stop and take notice. This time, it's the alliance between the Infocomm Media Development Authority (IMDA) and the National University Hospital (NUH) in Singapore. By launching an Open Innovation Platform (OIP) partnership, they've embarked on a journey...

Continue Reading
OppFi's Q3 2026: Is Their Growth Strategy on Track?

Updated Category News Views 14

OppFi's Third Quarter Performance Unpacked OppFi's recent third-quarter disclosures should get investors pondering. They've launched a new line of credit product, plugging a gap in their service portfolio, and aimed to widen their customer net. Their targeted share repurchase of $6.7 million in stock isn't small potatoes either, showing a vote of confidence in their own...

Continue Reading
Lennox Faces Pressures Amidst Strong Revenue Growth

Updated Category News Views 0

Revenue Surge but Margin Squeeze Out there in the land of HVAC, Lennox International (NYSE: LII) just dropped its third quarter earnings for 2026. Sure, they raked in a solid $1.6 billion—up a hearty 10%. But all that glitters ain't gold, and the company's operating income took a hit down to $312 million, shedding a cool five percent from last year. Challenges Weighing...

Continue Reading
Digimon Card Game Ventures into Digital Realms

Updated Category News Views 40

A Bold Leap for the Digimon Card Game Folks, if you've been tapping your foot waiting for Digimon to fire up a serious digital game, well, here's your moment. BANDAI CO., LTD. is rolling the dice as they launch pre-registration for DIGIMON ALYSION, a digital twist on the classic card game, across 49 countries. It's not just a game; it's a reimagining. They're not just...

Continue Reading

Top 5 Most Recently Viewed Articles

Ripple Banking License: Unlocking New Opportunities for XRP

Updated Category News Views 129

Ripple Banking License: Unlocking New Opportunities for XRP In recent developments, Ripple is on the brink of obtaining a banking license, a significant milestone that promises to reshape its role within the traditional financial sector. This pivotal moment not only ratifies Ripple’s credibility but also enhances the use of XRP among its holders. The acquisition of a...

Continue Reading
SEI's Dividend: $0.52 a Share May 2026 Call

Updated Category News Views 22

SEI's Dividends Sweeten the Pot In a world where every market shift feels like someone moving your chair just as you sit down, SEI Investments (NASDAQ: SEIC) keeps a consistent beat. They've declared a semi-annual dividend of $0.52 per share, and let me tell you, that's music to any income-seeking investor's ears right now. Those looking for steady returns in this...

Continue Reading
Solana Experiences a Significant Price Surge of 6.18%

Updated Category News Views 48

Solana price jumps 6.18% to $134.95 Solana added 6.18% in the latest session, bringing the price to $134.95. The move points to firm trading momentum as the market keeps a close eye on SOL. Gains like this usually appear when interest broadens and activity picks up, even if the day-to-day path isn’t perfectly smooth. One-week trend: steady gains from $130.33 Beyond the...

Continue Reading
BD Strengthens Future Plans with Strategic Business Separation

Updated Category News Views 1181

BD Announces Strategic Separation of Business Units BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, has taken a bold step by announcing a plan to separate its Biosciences and Diagnostics Solutions divisions from the rest of the organization. This strategic separation aims to enhance focus, drive growth, and unlock substantial...

Continue Reading
Understanding Solana's Recent Price Decline and Market Impact

Updated Category News Views 273

Analyzing Solana's Price Drop In the last day, Solana has encountered a significant decrease in its price, falling by more than 9% and currently valued at $120.87. This price drop is part of a broader downward trend observed over the past week, where the cryptocurrency recorded a staggering loss of 22%. The decline in value from $157.77 to its present figure illustrates...

Continue Reading